(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
----------
AIM - WINNERS
----------
Verici Dx PLC, up 21% at 9.1 pence, 12-month range 11p-40p. The Tennessee-based developer of clinical diagnostics for organ transplants says it achieves CLIA compliance certification for its commercial clinical operations to 45 US states. Now intends to ramp up commercialisation of its advanced kidney transplant service offering, which includes Tutivia. "This milestone of certification is also a key requirement to obtaining insurance reimbursement coverage under Medicare under the local coverage determination application being submitted this year," Verici explains.
----------
Poolbeg Pharma PLC, up 22% at 10.35p, 12-month range 4p-11.1p. The infectious disease-focused biopharmaceutical company announces positive data from the POLB 001 LPS human challenge trial. POLB 001 is a bacterial lipopolysaccharide treatment being developed for severe influenza. Poolbeg says the treatment was shown to be safe, well tolerated and potent against systemic and localised inflammation. The results show POLB 001's potential as a "blockbuster treatment" for severe influenza, the firm says.
----------
AIM - LOSERS
----------
Totally PLC, down 26% at 21p, 12-month range 20p-49.19p. The healthcare provider says it expects earnings before interest, tax, depreciation and amortisation to be around GBP6.3 million, which is below market consensus, for the financial year ending March 31. "The company has...been impacted by the combined impact of high inflation, national strikes, which increase pressure on services and scheduling, and clinical workforce shortages which increase reliance on agency staff for the delivery of urgent care services," Totally explains. Expects revenue to be in line with market consensus, and remains confident in its prospects.
----------
Metal Tiger, down 25% at 9.37p, 12-month range 8.55p-22.45p. The investor in natural resource opportunities plans to delist from AIM, in order to pursue a more "active" strategy than the listing requirements currently permit. Has abandoned previous notion of listing on the Specialist Fund Segment of London's Main Market. Will retain listing on Australian Securities Exchange. "The board believes that this will result in the company having greater flexibility to manage its portfolio," it explains. Will hold general meeting on March 20 for shareholder vote. Also, plans to change name to Strata Investment Holdings PLC, but notes this does not require shareholder approval.
----------
By Elizabeth Winter, Alliance News senior markets reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
